Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-14-002613
Filing Date
2014-02-12
Accepted
2014-02-12 17:27:00
Documents
1
Period of Report
2014-02-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 22371
  Complete submission text file 0001179110-14-002613.txt   23923
Mailing Address 101 LINDENWOOD DRIVE SUITE 225 MALVERN PA 19355
Business Address 101 LINDENWOOD DRIVE SUITE 225 MALVERN PA 19355 484-875-3095
Egalet Corp (Issuer) CIK: 0001586105 (see all company filings)

EIN.: 463575334 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address LAUTRUPSGADE 7, 5 COPENHAGEN O G7 DK-2100
Business Address LAUTRUPSGADE 7, 5 COPENHAGEN O G7 DK-2100 45-2012-6000
SUNSTONE LIFE SCIENCE VENTURES FUND II K/S (Reporting) CIK: 0001591179 (see all company filings)

State of Incorp.: G7 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36295 | Film No.: 14601566